Skip to content
Altius – Lifestyle
Author:
Essential Pharma
FOR INVESTORS AND FINANCIAL AND BUSINESS MEDIA ONLY Renaissance Pharma secures FDA Breakthrough Therapy Designation for daretabart in newly diagnosed high-risk neuroblastoma
November 16, 2026
Essential Pharma and Nordmark announce new partnership and UK availability of Norzyme® (pancreas powder) 25,000 gastro-resistant capsules for pancreatic exocrine insufficiency
November 9, 2026
Essential Pharma appoints Becki Morison as Chief Executive Officer
June 18, 2026